These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 35008316)
1. BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL. Garland GD; Ducray SP; Jahangiri L; Pucci P; Amos Burke GA; Monahan J; Lai R; Merkel O; Schiefer AI; Kenner L; Bannister AJ; Turner SD Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008316 [TBL] [Abstract][Full Text] [Related]
2. The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein. Pearson JD; Mohammed Z; Bacani JT; Lai R; Ingham RJ BMC Cancer; 2012 Jun; 12():229. PubMed ID: 22681779 [TBL] [Abstract][Full Text] [Related]
3. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma. Gao J; Yin M; Zhu Y; Gu L; Zhang Y; Li Q; Jia C; Ma Z BMC Cancer; 2013 Oct; 13():471. PubMed ID: 24112608 [TBL] [Abstract][Full Text] [Related]
5. Regulation of CD45 phosphatase by oncogenic ALK in anaplastic large cell lymphoma. Mura G; Karaca Atabay E; Menotti M; Martinengo C; Ambrogio C; Giacomello G; Arigoni M; Olivero M; Calogero RA; Chiarle R; Voena C Front Oncol; 2022; 12():1085672. PubMed ID: 36698412 [TBL] [Abstract][Full Text] [Related]
6. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner. Hsu FY; Johnston PB; Burke KA; Zhao Y Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741 [TBL] [Abstract][Full Text] [Related]
7. Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. Riera L; Lasorsa E; Ambrogio C; Surrenti N; Voena C; Chiarle R J Biol Chem; 2010 Aug; 285(34):26441-50. PubMed ID: 20554525 [TBL] [Abstract][Full Text] [Related]
8. Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma. Christensen JG; Zou HY; Arango ME; Li Q; Lee JH; McDonnell SR; Yamazaki S; Alton GR; Mroczkowski B; Los G Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3314-22. PubMed ID: 18089725 [TBL] [Abstract][Full Text] [Related]
9. NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma. Pearson JD; Lee JK; Bacani JT; Lai R; Ingham RJ Int J Clin Exp Pathol; 2011 Jan; 4(2):124-33. PubMed ID: 21326808 [TBL] [Abstract][Full Text] [Related]
10. Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity. Cussac D; Greenland C; Roche S; Bai RY; Duyster J; Morris SW; Delsol G; Allouche M; Payrastre B Blood; 2004 Feb; 103(4):1464-71. PubMed ID: 14563642 [TBL] [Abstract][Full Text] [Related]
12. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target. Werner MT; Zhao C; Zhang Q; Wasik MA Blood; 2017 Feb; 129(7):823-831. PubMed ID: 27879258 [TBL] [Abstract][Full Text] [Related]
13. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma. Bohling SD; Jenson SD; Crockett DK; Schumacher JA; Elenitoba-Johnson KS; Lim MS Leuk Res; 2008 Mar; 32(3):383-93. PubMed ID: 17720243 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Wellmann A; Otsuki T; Vogelbruch M; Clark HM; Jaffe ES; Raffeld M Blood; 1995 Sep; 86(6):2321-8. PubMed ID: 7662979 [TBL] [Abstract][Full Text] [Related]
15. Studies of phosphoproteomic changes induced by nucleophosmin-anaplastic lymphoma kinase (ALK) highlight deregulation of tumor necrosis factor (TNF)/Fas/TNF-related apoptosis-induced ligand signaling pathway in ALK-positive anaplastic large cell lymphoma. Wu F; Wang P; Zhang J; Young LC; Lai R; Li L Mol Cell Proteomics; 2010 Jul; 9(7):1616-32. PubMed ID: 20393185 [TBL] [Abstract][Full Text] [Related]